Literature DB >> 18801863

Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.

W Todd Cade1.   

Abstract

Physical therapists commonly treat people with diabetes for a wide variety of diabetes-associated impairments, including those from diabetes-related vascular disease. Diabetes is associated with both microvascular and macrovascular diseases affecting several organs, including muscle, skin, heart, brain, and kidneys. A common etiology links the different types of diabetes-associated vascular disease. Common risk factors for vascular disease in people with diabetes, specifically type 2 diabetes, include hyperglycemia, insulin resistance, dyslipidemia, hypertension, tobacco use, and obesity. Mechanisms for vascular disease in diabetes include the pathologic effects of advanced glycation end product accumulation, impaired vasodilatory response attributable to nitric oxide inhibition, smooth muscle cell dysfunction, overproduction of endothelial growth factors, chronic inflammation, hemodynamic dysregulation, impaired fibrinolytic ability, and enhanced platelet aggregation. It is becoming increasingly important for physical therapists to be aware of diabetes-related vascular complications as more patients present with insulin resistance and diabetes. The opportunities for effective physical therapy interventions (such as exercise) are significant.

Entities:  

Mesh:

Year:  2008        PMID: 18801863      PMCID: PMC2579903          DOI: 10.2522/ptj.20080008

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  171 in total

1.  Exercise training by individuals with predialysis renal failure: cardiorespiratory endurance, hypertension, and renal function.

Authors:  M L Boyce; R A Robergs; P S Avasthi; C Roldan; A Foster; P Montner; D Stark; C Nelson
Journal:  Am J Kidney Dis       Date:  1997-08       Impact factor: 8.860

2.  Association of physical activity and renal function in subjects with and without metabolic syndrome: a review of the Third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Joseph Finkelstein; Ashish Joshi; Michael K Hise
Journal:  Am J Kidney Dis       Date:  2006-09       Impact factor: 8.860

Review 3.  Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy.

Authors:  E M Kohner; V Patel; S M Rassam
Journal:  Diabetes       Date:  1995-06       Impact factor: 9.461

Review 4.  The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.

Authors:  S Chen; S W Hong; M C Iglesias-de la Cruz; M Isono; A Casaretto; F N Ziyadeh
Journal:  Ren Fail       Date:  2001 May-Jul       Impact factor: 2.606

5.  Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

Authors:  Pedro Romero; Mercè Salvat; Juan Fernández; Marc Baget; Inmaculada Martinez
Journal:  J Diabetes Complications       Date:  2007 Mar-Apr       Impact factor: 2.852

Review 6.  Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.

Authors:  Sho-ichi Yamagishi; Tsutomu Imaizumi
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

7.  Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes.

Authors:  Yiling J Cheng; Michael S Lauer; Conrad P Earnest; Timothy S Church; James B Kampert; Larry W Gibbons; Steven N Blair
Journal:  Diabetes Care       Date:  2003-07       Impact factor: 19.112

8.  The prevalence of diabetic retinopathy among adults in the United States.

Authors:  John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman
Journal:  Arch Ophthalmol       Date:  2004-04

9.  Homocysteine and diabetic retinopathy.

Authors:  Laima Brazionis; Kevin Rowley; Catherine Itsiopoulos; Colin Alexander Harper; Kerin O'Dea
Journal:  Diabetes Care       Date:  2007-09-26       Impact factor: 19.112

10.  Diabetes as a risk factor for stroke. A population perspective.

Authors:  B Stegmayr; K Asplund
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

View more
  202 in total

1.  Hierarchical Bayesian Logistic Regression to forecast metabolic control in type 2 DM patients.

Authors:  Arianna Dagliati; Alberto Malovini; Pasquale Decata; Giulia Cogni; Marsida Teliti; Lucia Sacchi; Carlo Cerra; Luca Chiovato; Riccardo Bellazzi
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

2.  Low back pain in diabetes mellitus and importance of preventive approach.

Authors:  Maghsoud Eivazi; Laleh Abadi
Journal:  Health Promot Perspect       Date:  2012-07-01

Review 3.  A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤ 35 kg/m2 undergoing Roux-en-Y gastric bypass.

Authors:  Wen-Sheng Rao; Cheng-Xiang Shan; Wei Zhang; Dao-Zhen Jiang; Ming Qiu
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

Review 4.  Insulin resistance in ischemic stroke.

Authors:  Xiao-Ling Deng; Zhou Liu; Chuanling Wang; Yanfeng Li; Zhiyou Cai
Journal:  Metab Brain Dis       Date:  2017-06-21       Impact factor: 3.584

Review 5.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

6.  Plantar stresses on the neuropathic foot during barefoot walking.

Authors:  Michael J Mueller; Dequan Zou; Kathryn L Bohnert; Lori J Tuttle; David R Sinacore
Journal:  Phys Ther       Date:  2008-09-18

7.  Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function.

Authors:  Tiffany N Hilton; Lori J Tuttle; Kathryn L Bohnert; Michael J Mueller; David R Sinacore
Journal:  Phys Ther       Date:  2008-09-18

8.  Diabetes mellitus and gait dysfunction: possible explanatory factors.

Authors:  Jennifer S Brach; Jaime B Talkowski; Elsa S Strotmeyer; Anne B Newman
Journal:  Phys Ther       Date:  2008-09-18

Review 9.  Epidemiology of diabetes and diabetes-related complications.

Authors:  Anjali D Deshpande; Marcie Harris-Hayes; Mario Schootman
Journal:  Phys Ther       Date:  2008-09-18

10.  Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulation.

Authors:  Federico Biscetti; Giuseppe Straface; Vincenzo Arena; Egidio Stigliano; Giovanni Pecorini; Paola Rizzo; Giulia De Angelis; Luigi Iuliano; Giovanni Ghirlanda; Andrea Flex
Journal:  Cardiovasc Diabetol       Date:  2009-09-08       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.